Patent Expiry
Patent/Exclusivity Expiry: SEGLENTIS
Other upcoming events for BDTX
Patent ExpiryPatent/Exclusivity Expiry: FIBRICOR
Phase 2 ReadoutPhase 2 Readout: silevertinib
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnos
Phase 3 ReadoutPhase 3 Topline: PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma
Patent ExpiryPatent/Exclusivity Expiry: IWILFIN
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.